4//SEC Filing
Haddadin Yezan Munther 4
Accession 0001209191-22-053354
CIK 0001649989other
Filed
Oct 10, 8:00 PM ET
Accepted
Oct 11, 5:05 PM ET
Size
6.7 KB
Accession
0001209191-22-053354
Insider Transaction Report
Form 4
Haddadin Yezan Munther
Director
Transactions
- Purchase
Common Stock
2022-10-07$1.27/sh+3,600$4,572→ 63,343 total - Purchase
Common Stock
2022-10-06$1.29/sh+29,743$38,368→ 59,743 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.279 - $1.2915, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
Documents
Issuer
Outlook Therapeutics, Inc.
CIK 0001649989
Entity typeother
Related Parties
1- filerCIK 0001718004
Filing Metadata
- Form type
- 4
- Filed
- Oct 10, 8:00 PM ET
- Accepted
- Oct 11, 5:05 PM ET
- Size
- 6.7 KB